| This week's sponsor is Premier Research. | |  | Overcoming Risk in Oncology Drug Development
Oncology drug development is full of potential obstacles and risks, and you must carefully plan each step. Click here for tips on finding the fast track. Premier Research. Built for biotech. |
Today's Rundown Featured Story | | | Monday, July 15, 2019 Gilead is paying $5.1 billion (€4.5 billion) to enter into a 10-year collaboration with Galapagos. The deal gives Gilead access to all of Galapagos’ current and future programs outside of Europe. |
|
|
Top Stories Monday, July 15, 2019 German pharma Boehringer Ingelheim is putting a few hundred million euros on the table to snap up Swiss cancer biotech Amal Therapeutics. Monday, July 15, 2019 Boehringer signed a deal to buy out a small, private immuno-oncology player this morning, and AbbVie’s been at it, too, inking a deal to snap up Mavupharma. Monday, July 15, 2019 Johnson & Johnson is gearing up to test a HIV vaccine in a 3,800-person clinical trial. The preparations follow animal studies that showed the vaccine offered better protection than earlier attempts to confer immunity to the virus. Monday, July 15, 2019 Neon Therapeutics’ personalized neoantigen vaccine coupled with Bristol-Myers Squibb’s Opdivo kept cancer at bay longer than Opdivo alone in patients with lung cancer, bladder cancer and melanoma. Monday, July 15, 2019 The FDA did not approve Eton Pharmaceuticals’ eye drop for allergic conjunctivitis, serving up a complete response letter that raised “no concerns” about the clinical data in the drug’s application. Monday, July 15, 2019 The FDA approval of Karyopharm Therapeutics' new product Xpovio to treat multiple myeloma,is quite limited, but one research group sees potential for Xpovio in another cancer type: glioblastoma. | This week's sponsor is Medrio. | |  | [Webinar] Accelerating Site and Patient Enrollment for Phase 1 Trials
Tuesday, July 23 | 2pm ET / 11am PT
This Fierce webinar will feature clinical trial site leaders and R&D executives, who will pass along the latest strategies for boosting site and patient enrollment in phase 1 trials. They will discuss best practices for communicating with both investigators and patients. Register Now! |
Resources Sponsored by: Reprints Desk, Inc. Cut your research time in half! Sponsored by: Almac Group Innovative Just in Time Manufacturing solution enables sponsors full late stage customisation of clinical trial materials Sponsored by: PwC How are employer activism strategies beginning to replace the cost-sharing of the past, and improve the health of the workforce? Sponsored by: United Cargo and SAVSU Technologies The combination of SAVSU technology with United Airlines’ global network has made it easier than ever to bring cell and gene therapies to destinations beyond major markets. Sponsored by: XiltriX North America Find out in this article how your pharmaceutical organization can leverage IoT technologies and informatics integration to innovate and improve overall operational efficiencies. Sponsored by: Patheon, by Thermo Fisher Scientific When a biologics company prepares to launch a new product, it must forecast the manufacturing capacity it will need. Learn more here. Sponsored by: Veradigm Patient demand for more information on their care is driving new e-prescribing regulations, and technology is evolving to help providers meet them. This report provides an overview of key areas where such regulation has emerged, and what it could mean for providers and healthcare IT companies. Sponsored by: Patheon, by Thermo Fisher Scientific Anticipate challenges in formulation early. Sponsored by: Titian Software This Essential Guide to Managing Laboratory Samples is a three-part piece exploring common problems experienced in the management of samples and how, for any scale of operation, significant efficiency and accuracy benefits can be gained using dedicated sample management software. Sponsored by: Veradigm Patients living with diabetes deserve better – Real-World Evidence for effecting/realizing change in the management of type 2 diabetes and cardiovascular/renal comorbidities. Sponsored by: Catalent Download the case study to learn about the clinical supply management tools that helped a small sized pharma company during phase III of a multi-arm oncology study. Sponsored by: Catalent Watch a short video on demand led supply model. It is designed to meet the needs of patients, clinical sites, clinical team and sponsors and results in shorter lead time, less waste, less stock out risk and no booklet labels. Sponsored by: Catalent Download the eBook to explore a proactive approach for clinical supply management. | 
